Kiniksa Pharmaceuticals International, plc
KNSA
$40.59
$0.521.30%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 35.92M | 4.79M | -16.95M | -43.19M | -9.07M |
| Total Depreciation and Amortization | 1.49M | 1.50M | 1.57M | 1.70M | 1.84M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 46.00M | 34.58M | 41.57M | 42.38M | 18.17M |
| Change in Net Operating Assets | 19.45M | 26.07M | 17.83M | 24.81M | 311.00K |
| Cash from Operations | 102.86M | 66.95M | 44.03M | 25.69M | 11.24M |
| Capital Expenditure | -1.13M | -457.00K | -292.00K | -277.00K | -140.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 25.00K | 25.00K | 25.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -51.76M | 3.98M | -39.13M | 37.92M | -42.40M |
| Cash from Investing | -52.89M | 3.52M | -39.39M | 37.67M | -42.52M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 34.90M | 28.05M | 16.44M | 17.25M | 15.49M |
| Repurchase of Common Stock | -7.39M | -5.75M | -5.02M | -4.98M | -4.67M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 27.51M | 22.30M | 11.42M | 12.27M | 10.82M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 77.48M | 92.77M | 16.05M | 75.63M | -20.45M |